Raida M - Search Results

1

A phase II study of weekly high-dose 5-fluorouracil and leucovorin plus biweekly alternating doxorubicin and cisplatin for advanced gastric carcinoma.

Raida M, Kath R, Arnrich M, Kähler G, Scheele J, Höffken K. Raida M, et al. J Cancer Res Clin Oncol. 1998;124(6):335-40. doi: 10.1007/s004320050179. J Cancer Res Clin Oncol. 1998. PMID: 9692842 Clinical Trial.

2

Chronomodulated chemotherapy in metastatic gastrointestinal cancer combining 5-FU and sodium folinate with oxaliplatin, irinotecan or gemcitabine: the Jena experience in 79 patients.

Kliche KO, Kubsch K, Raida M, Masri-Zada R, Höffken K. Kliche KO, et al. Among authors: raida m. J Cancer Res Clin Oncol. 2002 Sep;128(9):516-24. doi: 10.1007/s00432-002-0363-0. Epub 2002 Aug 21. J Cancer Res Clin Oncol. 2002. PMID: 12242517 Clinical Trial.

3

Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls.

Raida M, Schwabe W, Häusler P, Van Kuilenburg AB, Van Gennip AH, Behnke D, Höffken K. Raida M, et al. Clin Cancer Res. 2001 Sep;7(9):2832-9. Clin Cancer Res. 2001. PMID: 11555601

4

Circadian variation of dihydropyrimidine dehydrogenase mRNA expression in leukocytes and serum cortisol levels in patients with advanced gastrointestinal carcinomas compared to healthy controls.

Raida M, Kliche KO, Schwabe W, Häusler P, Clement JH, Behnke D, Höffken K. Raida M, et al. J Cancer Res Clin Oncol. 2002 Feb;128(2):96-102. doi: 10.1007/s00432-001-0309-y. Epub 2001 Nov 30. J Cancer Res Clin Oncol. 2002. PMID: 11862480

5

Expression, regulation and clinical significance of bone morphogenetic protein 6 in esophageal squamous-cell carcinoma.

Raida M, Sarbia M, Clement JH, Adam S, Gabbert HE, Höffken K. Raida M, et al. Int J Cancer. 1999 Sep 24;83(1):38-44. doi: 10.1002/(sici)1097-0215(19990924)83:1<38::aid-ijc8>3.0.co;2-b. Int J Cancer. 1999. PMID: 10449605

6

Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells.

Clement JH, Raida M, Sänger J, Bicknell R, Liu J, Naumann A, Geyer A, Waldau A, Hortschansky P, Schmidt A, Höffken K, Wölft S, Harris AL. Clement JH, et al. Among authors: raida m. Int J Oncol. 2005 Aug;27(2):401-7. Int J Oncol. 2005. PMID: 16010421

7

Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis.

Raida M, Clement JH, Leek RD, Ameri K, Bicknell R, Niederwieser D, Harris AL. Raida M, et al. J Cancer Res Clin Oncol. 2005 Nov;131(11):741-50. doi: 10.1007/s00432-005-0024-1. Epub 2005 Nov 1. J Cancer Res Clin Oncol. 2005. PMID: 16136355

8

[New agents for solid tumours].

Raida M. Raida M. Dtsch Med Wochenschr. 2006 Oct 27;131(43):2407-10. doi: 10.1055/s-2006-955023. Dtsch Med Wochenschr. 2006. PMID: 17054057 Review. German. No abstract available.

9

Expression of bone morphogenetic protein 2 in breast cancer cells inhibits hypoxic cell death.

Raida M, Clement JH, Ameri K, Han C, Leek RD, Harris AL. Raida M, et al. Int J Oncol. 2005 Jun;26(6):1465-70. Int J Oncol. 2005. PMID: 15870857

10

Circulating endothelial progenitor cells are inversely correlated with the median oxygen tension in the tumor tissue of patients with cervical cancer.

Raida M, Weiss T, Leo C, Lenz D, Tarnok A, Ameri K, Harris AL, Höckel M, Niederwieser D. Raida M, et al. Oncol Rep. 2006 Sep;16(3):597-601. doi: 10.3892/or.16.3.597. Oncol Rep. 2006. PMID: 16865261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters